---
schema_version: "secwatch.filing_event.v1"
accession: "0000096943-26-000036"
form_type: "8-K"
ticker: "TFX"
cik: "0000096943"
company_name: "TELEFLEX INC"
filed_at: "2026-03-27T23:59:59+00:00"
generated_at: "2026-05-15T08:46:18.831481+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Teleflex responds to Irenic; reaffirms $1.8B sale proceeds for $1B buyback, $800M debt paydown, $50M cost savings

## Summary
- Sale transactions of Acute Care, Interventional Urology, and OEM on track for H2 2026 close.
- Expected net proceeds of ~$1.8B after tax to fund $1.0B share repurchase and $800M debt paydown.
- Multi-year restructuring targets ~$50M annual pre-tax cost savings by mid-2028.
- Board has not rebuffed acquirer approaches; will consider bona fide proposals.
- CEO search ongoing; interim CEO Stu Randle leading restructuring plan.

## SEC filing metadata
- accession: 0000096943-26-000036
- form_type: 8-K
- ticker: TFX
- cik: 0000096943
- company_name: TELEFLEX INC
- filed_at: 2026-03-27T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/96943/000009694326000036/0000096943-26-000036-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/96943/000009694326000036/tfx-20260327.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000096943-26-000036
- JSON: https://secwatch.observer/filing/0000096943-26-000036.json
- Plain text: https://secwatch.observer/filing/0000096943-26-000036.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.